Credit Suisse’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-10,801
Closed -$61K 4950
2014
Q1
$61K Buy
+10,801
New +$67K ﹤0.01% 4566

Other funds holding RNA

Credit Suisse's RNA Position: Q2 2014 in Review

Credit Suisse sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q2 2014, closing a stake of 10,801 shares — an estimated $61K sold.

Credit Suisse first reported a position in RNA in Q1 2014 and held it in 1 quarter. The position peaked at $61K in Q1 2014. 42 funds tracked by Wall St. Rank hold RNA as of Q2 2014.

  • Credit Suisse reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q2 2014 after selling out during the quarter.
  • Credit Suisse sold 10,801 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q2 2014, an estimated $61K.
  • Credit Suisse first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q1 2014 and held it in 1 quarter.
  • Credit Suisse's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $61K in Q1 2014.
  • 42 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.